Eirini Papapetrou, MD, PhD
img_Eirini Papapetrou
PROFESSOR | Oncological Sciences
PROFESSOR | Medicine, Hematology and Medical Oncology
Research Topics
Cancer Genetics, Hematopoiesis, Stem Cells
Multi-Disciplinary Training Area
Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Disease Mechanisms and Therapeutics (DMT)
Research overview:


Visit the Papapetrou Laboratory

MD, University of Patras, Greece

PhD, University of Patras, Greece

Postdoctoral, Memorial Sloan-Kettering Cancer Center

2021

American Association for Cancer Research (AACR)-MPM oncology charitable foundation transformative cancer research award

2018

Leukemia & Lymphoma Society (LLS) Scholar Award

2018

Elected member of the American Society for Clinical Investigation (ASCI)

2017

Pershing Square Sohn Prize

2016

Outstanding New Investigator Award

American Society of Gene and Cell Therapy (ASGCT)

2015

Tito Bastianello Young Investigator Award

MDS International Foundation

2014

American Society for Clinical Investigation Young Physician-Scientist Award

American Society for Clinical Investigation (ASCI)

2013

American Society of Hematology (ASH) Junior Faculty Scholar Award

American Society of Hematology (ASH)

2013

Sidney Kimmel Foundation Scholar Award

Sidney Kimmel Foundation for Cancer Research

2013

Aplastic Anemia & MDS IF Research Grant Award

Aplastic Anemia & MDS International Foundation

2013

John H. Tietze Stem Cell Scientist Award

2013

Ellison Medical Foundation New Scholar in Aging Award

Ellison Medical Foundation

2013

Damon Runyon-Rachleff Innovation Award

Damon Runyon Cancer Research Foundation

2013

UW Royalty Research Fund Award

University of Washington

2011

K99/R00 Pathway to Independence Award

NIH/NIDDK

What the AAMDSIF Research Grant meant for this researcher: Eirini Papapetrou, MD, PhD
Cancer Precision Medicine Retreat -- Session 5: Eirini Papapetrou

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Papapetrou during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Cellarity

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.